Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

Clinical trial NCT00286169 · TERMINATED

Trial details

NCT number: NCT00286169
Sponsor: Sumitomo Pharma Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2006-04-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.